Gene expression profile algorithm and test for determining prognosis of prostate cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8725426
SERIAL NO

13752199

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides algorithm-based molecular assays that involve measurement of expression levels of genes, or their co-expressed genes, from a biological sample obtained from a prostate cancer patient. The genes may be grouped into functional gene subsets for calculating a quantitative score useful to predict a likelihood of a clinical outcome for a prostate cancer patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MDXHEALTH SACAP BUSINESS CENTER RUE D'ABHOOZ 31 HERSTAL 4040

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cherbavaz, Diana San Francisco, US 8 39
Crager, Michael Menlo Park, US 11 78
Knezevic, Dejan Palo Alto, US 12 46
Lee, Mark Los Altos Hills, US 70 920
Maddala, Tara Sunnyvale, US 20 93
Millward, Carl L Burlingame, US 4 37
Novotny, William Menlo Park, US 44 306
Pelham, Robert J Belmont, US 14 59
Shak, Steve Hillsborough, US 19 505

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 13, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00